CNST News and Press, Constellation Pharmaceuticals Inc. From 04/06/20

CAMBRIDGE, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Richard Levy, M.D., has been appoi...

Stating the obvious, Baird analysts have created three lists of healthcare companies that may be worth a look considering their attractive valuations or relatively strong capitalizations amid the COVID-19 selloff. More news on: IDEAYA Biosciences, Inc., Surface Oncology, Inc., Jounce Thera...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Constellation Pharmaceuticals, Inc. (CNST) Q4 2019 Earnings Conference Call March 10, 2020 5:00 P.M. ET Company Participants Ron Aldridge - Senior Director, Investor Relations Jigar Raythatha - Chief Executive Officer Emma Reeve - Chief Financial Officer Conference Call Part...

Image source: The Motley Fool. Constellation Pharmaceuticals   (NASDAQ: CNST) Q4 2019 Earnings Call Mar 10, 2020 , 5:00 p.m. ET Operator Continue reading

Constellation Pharmaceuticals (NASDAQ: CNST ): Q4 GAAP EPS of -$0.69 beats by $0.02 . More news on: Constellation Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Clinical data presented at 2019 American Society of Hematology (ASH) annual meeting suggested that CPI-0610 could offer meaningful benefits beyond standard of care in myelofibrosis In addition to previously expanded MANIFEST Cohorts 3 and 2A, now expanding Cohort 1A Planning updat...

CAMBRIDGE, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a conference call at 5:00 PM EDT on March 10, 2020, to discuss its fo...

CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar Raythatha, CEO, will present ...